Athira Pharma (ATHA) IPO Opens 17% Higher

Today's IPO for Athira Pharma, Inc., (NASDAQ: ATHA) opened for trading at $19.95 after pricing 12,000,000 shares of its common stock at a price to the public of $17.00 per share

Goldman Sachs & Co. LLC, Jefferies and Stifel are acting as joint book-running managers for the offering. JMP Securities is acting as co-manager.

Athira Pharma, Inc. is a a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration.

You May Also Be Interested In

• Robinhood Ventures Fund II prices IPO at $25 per share on NYSE
• Thunder Bridge Capital Partners V prices $261M IPO on Nasdaq
• Lyntris (LYNX) files for 24M share IPO at $19-$22/sh